Solid Phase Extraction Market Outlook:
Solid Phase Extraction Market size was over USD 393.07 million in 2025 and is poised to exceed USD 598.84 million by 2035, witnessing over 4.3% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of solid phase extraction is estimated at USD 408.28 million.
The rapidly expanding pharmaceutical and biotechnology sectors are offering lucrative opportunities for solid phase extraction solution producers. The need for purity and consistency in drug production and molecular biology and rising regulatory demands for product testing are set to augment the adoption of solid phase extraction technologies. For instance, the global pharmaceutical market was evaluated at USD 1.6 trillion in 2023. Pharma companies headquartered in New Brunswick and New Jersey totaled revenues of around USD 85.0 billion. Johnson & Johnson is the pharmaceutical leader across the world followed by Pfizer, Merck & Co., and AbbVie. North America and Europe followed by Asia Pacific are leading the future of the pharma and biopharma sectors. Furthermore, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) reveals that the biopharmaceutical sector is anticipated to witness a rise in R&D sending from USD 179.0 billion in 2020 to USD 213.0 billion by 2026. .
